Table 2 The Trigger Items of CHCMU and its PPV.

From: Adverse drug events in Chinese pediatric inpatients and associated risk factors: a retrospective review using the Global Trigger Tool

No

Triggers

Positive Triggers

ADEs

PPV (%)

Laboratory Index

L1

Partial thromboplastin time (PTT) > 100 s1,9,23

23

4

17.4

L2

International normalized ratio (INR) > 3.51,20

2

1

50.0

L3

Hypoglycaemia (≤2.8 mmol.L−1)20

13

5

38.5

L4

Hyperglycaemia (≥7.8 mmol.L−1)12,20

40

5

12.5

L5

Rising urea or creatinine (>2 × baseline)12

3

0

0

L6

Rising alanine aminotransferase or aspartate transaminase or total bilirubin and alkaline phosphatase (>2 × baseline)1

115

14

12.2

L7

Hypokalemia (<3 mmol.L−1)1,12

32

6

18.8

L8

Hyperkalemia (>5.5 mmol.L−1)1,20

89

1

1.1

L9

Hyponatremia (<130 mmol.L−1)1,12,20

12

1

8.3

L10

Leukocyte count < 3*109.L−123,24

13

3

23.1

L11

Platelets count < 50*109.L−112

0

0

0

L12

Elevated drug levels: Vancomycin > 30 mg.L−1\ Amikacin > 5 mg.L−11,20

0

0

0

L13

Phenytoin > 40 mg.L−1\ Valproic acid > 150 mg.L−1\Phenobarbital > 50 mg.L−1\Carbamazepine > 15 mg.L−1\Clonazepam > 80 µg.L−1\Nitrazepam > 200 µg.L−1\Oxcarbazepine > 35 mg.L−1\Phenobarbital > 20 mg.L−1[20]

0

0

0

L14

Cyclosporin A > 400 µg.L−1 (treatment)\> 500 µg.L−1 (transplantation of organ)

0

0

0

L15

Elevated drug levels: Digoxin > 2 µg.L−11,23

0

0

0

L16

Elevated drug levels: Lidocaine > 5 mg.L−123

0

0

0

L17

Elevated drug levels: Theophylline > 20 g.L−11,23

0

0

0

Antidotes

A1

Anti-allergic or Adrenaline use6

312

21

6.8

A2

Flumazenil use6

45

40

88.9

A3

Naloxone\Nalmefene use6

54

23

42.6

A4

Anti-emetic use6

303

21

6.9

A5

Ongoing or intermittent laxative use20

321

20

6.2

A6

Protamine use20

16

2

12.5

A7

Antidiarrheal or Antidiarrheal administration23

364

35

9.6

A8

Glutathione use

161

16

9.9

A9

Nystatin and Sodium bicarbonate use

25

25

100

Clinical Symptoms

S1

Over sedation\hypotension\falls9

6

2

33.3

S2

Rash9,24

285

35

12.3

Intervention Measures

T1

Abrupt medication stop6

15

13

86.7

T2

Transfer to higher level of care10,20

15

4

26.7

T3

Rescue20

27

7

25.9

 

Total

2291

304

13.3

  1. ADEs, Adverse drug events; it indicates the number of adverse drug events detected by triggers, and different triggers in a patient can indicate same adverse drug events.
  2. PPV, Positive predictive value; it indicates the percentage of triggers that predict ADEs.